BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37367817)

  • 21. Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/β-catenin signaling in human osteosarcoma cells.
    Zhang RX; Li Y; Tian DD; Liu Y; Nian W; Zou X; Chen QZ; Zhou LY; Deng ZL; He BC
    Int J Oncol; 2016 Nov; 49(5):1973-1982. PubMed ID: 27665868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway.
    Ding Q; Mo F; Cai X; Zhang W; Wang J; Yang S; Liu X
    J Cell Biochem; 2020 Jun; 121(5-6):3358-3371. PubMed ID: 31898343
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Zhang QH; Hu QX; Xie D; Chang B; Miao HG; Wang YG; Liu DZ; Li XD
    Integr Cancer Ther; 2019; 18():1534735419890917. PubMed ID: 31855073
    [No Abstract]   [Full Text] [Related]  

  • 24. Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt/β-catenin signaling pathway.
    Liu X; Li L; Lv L; Chen D; Shen L; Xie Z
    Oncol Rep; 2015 Aug; 34(2):1035-41. PubMed ID: 26035210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone morphogenetic protein-2 promotes osteosarcoma growth by promoting epithelial-mesenchymal transition (EMT) through the Wnt/β-catenin signaling pathway.
    Tian H; Zhou T; Chen H; Li C; Jiang Z; Lao L; Kahn SA; Duarte MEL; Zhao J; Daubs MD; Buser Z; Brochmann EJ; Wang JC; Murray SS
    J Orthop Res; 2019 Jul; 37(7):1638-1648. PubMed ID: 30737824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.
    Li Z; Yang Z; Liu W; Zhu W; Yin L; Han Z; Xian Y; Wen J; Tang H; Lin X; Yang Y; Wang J; Zhang K
    J Transl Med; 2023 May; 21(1):302. PubMed ID: 37147666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ALOX5AP suppresses osteosarcoma progression via Wnt/β-catenin/EMT pathway and associates with clinical prognosis and immune infiltration.
    Han GD; Dai J; Hui HX; Zhu J
    J Orthop Surg Res; 2023 Jun; 18(1):446. PubMed ID: 37344882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delphinidin induces apoptosis and inhibits epithelial-to-mesenchymal transition via the ERK/p38 MAPK-signaling pathway in human osteosarcoma cell lines.
    Kang HM; Park BS; Kang HK; Park HR; Yu SB; Kim IR
    Environ Toxicol; 2018 Jun; 33(6):640-649. PubMed ID: 29451351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor Effect of Docetaxel in Osteosarcoma by the Inhibition of Wnt Signal Channel.
    Wang DZ; Gao JF; Jing SF; Wei H; Huang XY; Li CD
    Drug Res (Stuttg); 2015 Nov; 65(11):597-601. PubMed ID: 25514117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabidiol inhibits invasion and metastasis in colorectal cancer cells by reversing epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
    Feng P; Zhu L; Jie J; Yang P; Sheng N; Chen X; Chen X
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3587-3598. PubMed ID: 35960375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigallocatechin-3-gallate suppresses the growth of human osteosarcoma by inhibiting the Wnt/β-catenin signalling pathway.
    Dong C; Wang Z; Shen P; Chen Y; Wang J; Wang H
    Bioengineered; 2022 Apr; 13(4):8490-8502. PubMed ID: 35348430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gallic acid alleviates gastric precancerous lesions through inhibition of epithelial mesenchymal transition via Wnt/β-catenin signaling pathway.
    Liao W; Wen Y; Wang J; Zhao M; Lv S; Chen N; Li Y; Wan L; Zheng Q; Mou Y; Zhao Z; Tang J; Zeng J
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115885. PubMed ID: 36328204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-148a-3p suppresses epithelial-to-mesenchymal transition and stemness properties via Wnt1-mediated Wnt/β-catenin pathway in pancreatic cancer.
    Fu X; Hong L; Yang Z; Tu Y; Xin W; Zha M; Tu S; Sun G; Li Y; Xiao W
    J Cell Mol Med; 2020 Nov; 24(22):13020-13035. PubMed ID: 33026174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of Sox2 Inhibits OS Cells Invasion and Migration via Modulating Wnt/β-Catenin Signaling Pathway.
    Tang L; Wang D; Gu D
    Pathol Oncol Res; 2018 Oct; 24(4):907-913. PubMed ID: 29619662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b.
    Liu Q; Wang Z; Zhou X; Tang M; Tan W; Sun T; Deng Y
    Cell Cycle; 2019 Dec; 18(23):3325-3336. PubMed ID: 31601147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Echinatin inhibits the growth and metastasis of human osteosarcoma cells through Wnt/β-catenin and p38 signaling pathways.
    Lu Q; Huang H; Wang X; Luo L; Xia H; Zhang L; Xu J; Huang Y; Luo X; Luo J
    Pharmacol Res; 2023 May; 191():106760. PubMed ID: 37023991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DHRS12 inhibits the proliferation and metastasis of osteosarcoma via Wnt3a/β-catenin pathway.
    Xu Z; He W; Ke T; Zhang Y; Zhang G
    Future Oncol; 2020 Apr; 16(11):665-674. PubMed ID: 32250163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.